Jon Edqvist1,2, Araz Rawshani1,2, Aidin Rawshani1,2, Martin Adiels1,3, Stefan Franzén4, Lena Bjorck1,2, Ann-Marie Svensson4, Marcus Lind1,5, Naveed Sattar6, Annika Rosengren7,2. 1. Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg, Västra Götaland, Sweden. 2. Region Västra Götaland, Sahlgrenska University Hospital, Goteborg, Sweden. 3. Department of Public Health and Community Medicine, University of Gothenburg Health Metrics Unit, Gothenburg, Sweden. 4. National Diabetes Register, Centre of Registers, Gothenburg, Sweden. 5. Medicine, Uddevalla Hospital, Uddevalia, Region of Vastra Gotaland, Sweden. 6. BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK. 7. Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg, Västra Götaland, Sweden annika.rosengren@gu.se.
Authors: Arcelia Arrieta; Tadej Battelino; Andrea E Scaramuzza; Julien Da Silva; Javier Castañeda; Toni L Cordero; John Shin; Ohad Cohen Journal: Diabetes Obes Metab Date: 2022-05-12 Impact factor: 6.408